Subscribe to RSS
DOI: 10.1055/s-0028-1088032
Efficient Synthesis of Two Sialylated Tetrasaccharides Found in Goat Milk
Publication History
Publication Date:
25 March 2009 (online)
Abstract
Two regioisomeric sialylated tetrasaccharides found in goat milk have been obtained in excellent yield by a concise synthesis using a common disaccharide intermediate. Regioselective glycosylations and a minimal number of protecting-group manipulations are the key features of this synthetic strategy.
Key words
oligosaccharides - glycosylations - sialic acid - goat milk - tetrasaccharides
Mammalian milk is an excellent source of complex oligosaccharide antigens and bifidus factors for breastfed newborns. To date, more than 130 different oligosaccharide structures have been isolated and characterized from different mammalian milks. [¹] For a long time, the biological significance of a large number of complex oligosaccharides found in milk were not properly studied because it was thought that they are not directly related to nutrition and were treated as byproducts formed during the synthesis of milk. Recently, it has been demonstrated that milk oligosaccharides have strong potential to inhibit pathogenic microbial adhesion to the host cell surface, which is the initial step of bacterial infections. [²] Oligosaccharides found in human milk can inhibit the adhesion of Streptococcus pneumoniae and Haemophilus influenzae to human pharyngeal or buccal epithelial cells and Escherichia coli adhesion to uroepithelial cells. [²] [³] A number of glycoproteins or glycolipids that function as tumor-associated antigens are found in human milk. [4] In addition, milk oligosaccharides may function as prebiotics, promoting the growth of benign microorganisms, such as Bifidobacterium bifidus, within the lower gastrointestinal tract, and inhibiting the proliferation of pathogenic organisms. [5] In spite of several investigations, the physiological role of the milk-derived oligosaccharides is not yet completely established. Different types of milk have been analyzed for their oligosaccharide structures that have immunological properties. [6] Recently, it has been reported that goat milk contains two regioisomeric sialylated tetrasaccharides. [7] Although these oligosaccharides can be isolated from the natural sources, it is essential to synthesize them chemically to provide larger quantities for their proper bioevaluations. We report herein the concise chemical synthesis of two sialylated tetrasaccharides found in goat milk (Figure [¹] ).

Figure 1 Structures of two synthesized sialylated tetrasaccharides as their 4-methoxyphenyl glycosides found in goat milk
Two regioisomeric sialylated tetrasaccharides 1 and 2 (Figure [¹] ) were synthesized from a common disaccharide derivative 8 in a very concise manner (Scheme [¹] and Scheme [²] ). For this purpose, a number of suitably protected monosaccharide synthons 3, [8] 4, [9] 5, [¹0] 6, [¹¹] and 7 [¹²] (Figure [²] ) were prepared from naturally available monosaccharides according to methodologies reported in the literature.

Scheme 1 Reagents and conditions: (a) NIS, TMSOTf, 4 Å MS, CH2Cl2, -30 ˚C, 45 min, 92%; (b) HClO4˙SiO2, MeCN-H2O (9:1), r.t., 30 min, 95%; (c) 5, TMSOTf, 4 Å MS, CH2Cl2, -40 ˚C, 1 h, 82%; (d) 0.1 M NaOMe, MeOH, r.t., 4 h, 100%; (e) 7, NIS, TfOH, 3 Å MS, MeCN-CH2Cl2 (5:1), -30 ˚C, 20 h, 50%; (f) 1. H2, 20% Pd(OH)2/C, MeOH, r.t., 24 h; 2. 0.1 M NaOMe, MeOH, r.t., 12 h, then H2O (5 drops), r.t., 6 h, 70%.

Scheme 2 Reagents and conditions: (a) 0.1 M NaOMe, MeOH, r.t., 2 h, 100%; (b) 1. 6, NIS, TMSOTf, CH2Cl2, 4 Å MS, -50 ˚C, 45 min; 2. Ac2O, py, r.t., 2 h, 74% (2 steps); (c) HClO4˙SiO2, MeCN-H2O (9:1), r.t., 30 min, 92%; (d) 7, NIS, TfOH, 3 Å MS, MeCN-CH2Cl2 (5:1), -30 ˚C, 20 h, 67%; (e) 1. H2, 20% Pd(OH)2/C, MeOH, r.t., 24 h; 2. 0.1 M NaOMe, MeOH, r.t., 12 h, then H2O (5 drops), r.t., 6 h, 72%.

Figure 2 Suitably protected monosaccharide intermediates used for the preparation of compounds 1 and 2
Condensation of monosaccharide acceptor 3 with thioglycoside donor 4 in the presence of a combination of N-iodosuccinimide and trimethylsilyl trifluoromethanesulfonate [¹³] furnished the disaccharide derivative 8 in 92% yield; this was the common starting point for the synthesis of both 1 (Scheme [¹] ) and 2 (Scheme [²] ). The presence of signals at δ = 5.46 (s, PhCH), 4.86 (d, J = 7.4 Hz, H-1A), and 4.70 (d, J = 8.1 Hz, H-1B) in the ¹H NMR and at δ = 102.8 (C-1A), 101.0 (PhCH), and 100.8 (C-1B) in the ¹³C NMR spectra confirmed its formation.
Removal of the benzylidene acetal from compound 8 by use of perchloric acid supported on silica [¹4] at room temperature resulted in the formation of disaccharide diol derivative 9 in 95% yield (Scheme [¹] ). Regioselective glycosylation of compound 9 with d-galactose-derived trichloroacetimidate derivative 5 in the presence of trimethylsilyl trifluoromethanesulfonate [¹5] afforded expected trisaccharide derivative 10 in 82% yield. Presence of ¹H NMR signals at δ = 4.86 (d, J = 8.0 Hz, H-1A), 4.61 (d, J = 3.9 Hz, H-1B), and 4.30 (d, J = 8.0 Hz, H-1C) and ¹³C NMR signals at δ = 102.9 (C-1A), 101.3 (C-1C), and 100.2 (C-1B) supported its formation. Compound 10 was deacetylated with sodium methoxide, to furnish trisaccharide triol acceptor 11 in quantitative yield, to be used for glycosylation with the sialic acid derivative. Stereo- and regioselective glycosylation [¹6] of sialic acid derived thioglycoside donor 7 with compound 11 in the presence of the N-iodosuccinimide-trifluoromethanesulfonic acid combination [¹³] in a mixed solvent (MeCN-CH2Cl2, 5:1) furnished sialylated tetrasaccharide derivative 12 in 50% yield. Hydrogenolysis of tetrasaccharide derivative 12 over Pearlman’s catalyst [¹7] followed by conventional saponification furnished tetrasaccharide 1 as its sodium salt and 4-methoxyphenyl glycoside in 80% overall yield; it was purified over Sephadex LH-20 gel (MeOH-H2O, 4:1) (Scheme [¹] ). The presence of signals at δ = 4.79 (d, J = 7.3 Hz, H-1A), 4.42 (d, J = 7.9 Hz, H-1B), 4.28 (d, J = 7.0 Hz, H-1C), 2.74 (dd, J = 12.1, 3.7 Hz, 1 H, H-3eD), and 1.87 (t, J = 11.8 Hz, 1 H, H-3aD) in the ¹H NMR and at δ = 104.3 (C-2D), 104.2 (2 C, C-1C, C-1B), and 101.9 (C-1A) in the ¹³C NMR spectra confirmed the formation of compound 1.
For the synthesis of compound 2 (Scheme [²] ), disaccharide derivative 8 was deacetylated with sodium methoxide to afford disaccharide diol acceptor 13 in quantitative yield. Compound 13 was regioselectively glycosylated with thioglycoside 6 under N-iodosuccinimide-trimethylsilyl trifluoromethanesulfonate catalysis; conventional acetylation followed, to furnish trisaccharide derivative 14 in 74% overall yield. Presence of signals at δ = 4.80 (d, J = 7.5 Hz, H-1A), 4.62 (d, J = 7.9 Hz, H-1B), and 4.58 (d, J = 8.0 Hz, H-1C) in the ¹H NMR and at δ = 102.7 (C-1A), 101.6 (C-1B), and 100.9 (C-1C) in the ¹³C NMR spectra confirmed its formation. Removal of the benzylidene acetal from compound 14 was achieved by use of perchloric acid supported on silica at room temperature; this gave trisaccharide diol derivative 15 in 92% yield. Stereo- and regioselective glycosylation of trisaccharide acceptor 15 with sialic acid thioglycoside derivative 7 in the presence of the N-iodosuccinimide-trifluoromethanesulfonic acid combination in a mixed solvent (MeCN-CH2Cl2, 5:1) furnished 6-O-α-sialylated tetrasaccharide derivative 16 in 67% yield. Hydrogenolysis of tetrasaccharide derivative 16 over Pearlman’s catalyst followed by conventional saponification furnished tetrasaccharide 2 as its sodium salt and 4-methoxyphenyl glycoside in 78% overall yield; it was purified over Sephadex LH-20 gel (MeOH-H2O, 4:1) (Scheme [²] ). The presence of signals at δ = 4.79 (d, J = 7.3 Hz, H-1A), 4.47 (d, J = 7.3 Hz, H-1B), 4.41 (d, J = 7.5 Hz, H-1C), 2.73 (dd, J = 12.3, 4.2 Hz, 1 H, H-3eD), and 1.75 (t, J = 11.9 Hz, 1 H, H-3aD) in the ¹H NMR and at δ = 105.3 (C-1B), 103.7 (C-1C), 101.9 (C-1A), 99.5 (C-2D) in the ¹³C NMR spectra supported the formation of compound 2.
In summary, efficient syntheses of two regioisomers of sialylated tetrasaccharides 1 and 2 found in goat milk were achieved in excellent yield. A common disaccharide derivative has been used as the starting point for the preparation of both tetrasaccharides in a minimal number of steps. Both tetrasaccharides contain the 4-methoxyphenyl group as a temporary anomeric protecting group, which can be removed by standard procedures for the preparation of glycoconjugates.
All the reactions were monitored by TLC on plates coated with silica gel. The TLC spots were visualized by warming the TLC plates sprayed with 2% Ce(SO4)2 in 2 N H2SO4 on a hot plate. Silica gel (230-400 mesh) was used for column chromatography. ¹H and ¹³C NMR, 2D COSY, and HSQC spectra were recorded on a Bruker Avance DPX 300 MHz spectrometer; CDCl3 and D2O were used as solvents and TMS as internal reference, unless stated otherwise. ESI-MS was carried out on a MICROMASS QUATTRO II triple quadrupole mass spectrometer. Elementary analysis was carried out on a Carlo ERBA-1108 analyzer. Optical rotations were measured at 25 ˚C on a Rudolf Autopol III polarimeter. Commercially available grades of organic solvents of adequate purity were used in many reactions.
4-Methoxyphenyl (2,3-Di- O -acetyl-4,6- O -benzylidene-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (8)
To a soln of 3 (5 g, 9 mmol) and thioglycoside donor 4 (4.3 g, 10.8 mmol) in CH2Cl2 (50 mL) was added 4 Å MS (5 g), and the mixture was allowed to stir at r.t. under argon for 30 min. The mixture was cooled to -30 ˚C and NIS (3.2 g, 14 mmol) and TMSOTf (30 µL) were added. After stirring of the mixture at the same temperature for 45 min, it was filtered through a Celite bed and washed with CH2Cl2 (100 mL). The organic layer was washed with 5% Na2S2O3 (100 mL), sat. NaHCO3 (100 mL), and H2O (100 mL) in succession, dried (Na2SO4), and evaporated to dryness. The crude mass was purified by chromatography (silica gel, hexane-EtOAc, 5:1); this gave pure 8.
Yield: 7.4 g (92%); R f = 0.3 (hexane-EtOAc, 3:1); white solid; mp 139-41 ˚C; [α]D ²5 -4.2 (c 1.5, CHCl3).
IR (KBr): 2915, 2871, 1740, 1506, 1454, 1374, 1230, 1061, 736, 698 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.49-7.19 (m, 20 H, Ar-H), 7.02 (d, J = 9.0 Hz, 2 H, Ar-H), 6.81 (d, J = 9.0 Hz, 2 H, Ar-H), 5.46 (s, 1 H, PhCH), 5.33 (dd, J = 10.3, 8.1 Hz, 1 H, H-2B), 5.12 (d, J = 11.0 Hz, 1 H, PhCH 2), 5.02 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.86 (d, J = 7.4 Hz, 1 H, H-1A), 4.84-4.73 (m, 4 H, H-3B, 3 PhCH 2), 4.70 (d, J = 8.1 Hz, 1 H, H-1B), 4.53 (d, J = 11.9 Hz, 1 H, PhCH 2), 4.25 (d, J = 3.4 Hz, 1 H, H-4B), 4.18 (d, J = 12.4 Hz, 1 H, H-6aB), 4.00 (t, J = 9.0 Hz, 1 H, H-3A), 3.87-3.75 (m, 3 H, H-6bB, H-6abA), 3.79 (s, 3 H, OCH 3), 3.72-3.66 (m, 3 H, H-2A, H-5A, H-5B), 3.52-3.46 (m, 1 H, H-4A), 2.09, 2.00 (2 s, 6 H, 2 COCH 3).
¹³C NMR (75 MHz, CDCl3): δ = 170.6, 168.9 (2 COCH3), 155.3-114.5 (Ar-C), 102.8 (C-1A), 101.0 (PhCH), 100.8 (C-1B), 82.9 (C-2A), 81.7 (C-5A), 77.4 (C-3A), 75.6 (PhCH2), 75.0 (3 C, PHCH2, C-4A, C-5B), 73.6 (PhCH2), 73.3 (C-4B), 72.2 (C-3B), 69.4 (C-2B), 68.6 (C-6B), 68.0 (C-6A), 55.6 (OCH3), 20.8 (2 C, COCH3).
ESI-MS: m/z = 913.2 [M + Na]+.
Anal. Calcd for C51H54O14 (890.35): C, 68.75; H, 6.11. Found: C, 68.58; H, 6.30.
4-Methoxyphenyl (2,3-Di- O -acetyl-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (9)
HClO4˙SiO2 (500 mg) was added to a soln of 8 (2.5 g, 2.8 mmol) in MeCN-H2O (9:1; 50 mL), and the mixture was allowed to stir at r.t. for 30 min. It was then filtered through a Celite bed and evaporated to dryness. The crude product was purified through a short pad of silica gel (hexane-EtOAc, 1:1); this gave pure 9.
Yield: 2.2 g (95%); R f = 0.2 (hexane-EtOAc, 1:2); white solid; mp 156-58 ˚C; [α]D ²5 -31.4 (c 1.5, CHCl3).
IR (KBr): 3432, 2870, 1743, 1508, 1455, 1373, 1229, 1059, 751, 698 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.43-7.29 (m, 15 H, Ar-H), 7.05 (d, J = 9.1 Hz, 2 H, Ar-H), 6.81 (d, J = 9.2 Hz, 2 H, Ar-H), 5.26 (dd, J = 10.1, 8.0 Hz, 1 H, H-2B), 5.02 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.98 (d, J = 11.2 Hz, 1 H, PhCH 2), 4.85-4.79 (m, 3 H, H-1A, PhCH 2), 4.75 (d, J = 10.4, 3.6 Hz, 1 H, H-3B), 4.70 (d, J = 11.9 Hz, 1 H, PhCH 2), 4.58 (d, J = 8.0 Hz, 1 H, H-1B), 4.52 (d, J = 11.9 Hz, 1 H, PhCH 2), 4.03-3.97 (m, 2 H, H-4B, H-3A), 3.73 (s, 3 H, OCH 3), 3.75-3.65 (m, 2 H, H-6abA), 3.63-3.60 (m, 2 H, H-2A, H-5A), 3.57-3.54 (m, 2 H, H-6abB), 3.52-3.48 (m, 1 H, H-4A), 3.25-3.22 (m, 1 H, H-5B), 2.09, 1.99 (2 s, 6 H, 2 COCH 3).
¹³C NMR (75 MHz, CDCl3): δ = 170.1, 169.3 (2 COCH3), 155.3-114.5 (Ar-C), 102.7 (C-1A), 100.3 (C-1B), 82.5 (C-2A), 81.3 (C-5A), 76.4 (C-3A), 75.3 (C-3B), 74.9 (PhCH2), 74.8 (PhCH2), 73.7 (C-4A), 73.5 (2 C, PhCH2, C-5B), 69.4 (C-2B), 68.1 (C-4B), 67.8 (C-6A), 62.1 (C-6B), 55.5 (OCH3), 20.7 (2 C, COCH3).
ESI-MS: m/z = 825.1 [M + Na]+.
Anal. Calcd for C44H50O14 (802.32): C, 65.82; H, 6.28. Found: C, 65.60; H, 6.50.
4-Methoxyphenyl (2- O -Acetyl-3,4,6-tri- O -benzyl-β- d -galactopyranosyl)-(1→6)-(2,3-di- O -acetyl-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (10)
A soln of 9 (2 g, 2.5 mmol) and 5 (2 g, 3.2 mmol) in anhyd CH2Cl2 (25 mL) was cooled to -50 ˚C. TMSOTf (100 µL) was added, and the mixture was stirred at -40 ˚C for 1 h. It was diluted with CH2Cl2 (50 mL), and the organic layer was washed with sat. aq NaHCO3 (100 mL) and H2O (100 mL) in succession, dried (Na2SO4), and evaporated to dryness. The crude product was purified by chromatography (silica gel, hexane-EtOAc, 2:1); this gave pure 10.
Yield: 2.6 g (82%); R f = 0.4 (hexane-EtOAc, 1:2); white solid; mp 176-78 ˚C; [α]D ²5 -17.3 (c 1.5, CHCl3).
IR (KBr): 3465, 2874, 1747, 1506, 1371, 1230, 1063, 747, 698 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.43-7.17 (m, 30 H, Ar-H), 7.00 (d, J = 9.0 Hz, 2 H, Ar-H), 6.80 (d, J = 9.0 Hz, 2 H, Ar-H), 5.28 (t, J = 9.0 Hz, 1 H, H-2C), 5.21 (t, 9.1 Hz, 1 H, H-2B), 4.97 (d, J = 11.1 Hz, 2 H, PhCH 2), 4.90 (d, J = 12.1 Hz, 1 H, PhCH 2), 4.86 (d, J = 8.0 Hz, 1 H, H-1A), 4.84-4.80 (m, 1 H, H-3B), 4.79 (d, J = 11.8 Hz, 1 H, PhCH 2), 4.78 (d, J = 12.0 Hz, 1 H, PhCH 2), 4.71 (d, J = 12.0 Hz, 1 H, PhCH 2), 4.61 (d, J = 3.9 Hz, 1 H, H-1B), 4.58-4.54 (d, J = 12.0 Hz, 3 H, PhCH 2), 4.49-4.39 (m, 3 H, PhCH 2), 4.30 (d, J = 8.0 Hz, 1 H, H-1C), 4.03-3.98 (m, 2 H, H-4B, H-3A), 3.85 (br s, 1 H, H-4C), 3.79 (s, 3 H, OCH 3), 3.76-3.73 (m, 2 H, H-6abA), 3.71-3.59 (m, 4 H, H-6abB, H-2A, H-5C), 3.55-3.39 (m, 5 H, H-6abC, H-5A, H-3C, H-4A), 3.32-3.26 (m, 1 H, H-5B), 2.09, 2.05, 1.99 (3 s, 9 H, 3 COCH 3).
¹³C NMR (75 MHz, CDCl3): δ = 169.8, 169.5, 169.1 (3 COCH3), 155.3-114.5 (Ar-C), 102.9 (C-1A), 101.3 (C-1C), 100.2 (C-1B), 82.8 (C-2A), 81.7 (C-5C), 80.7 (C-5A), 76.2 (C-3A), 75.7 (PhCH2), 74.9 (C-3C), 74.8 (PhCH2), 74.4 (PhCH2), 73.5 (2 C, PhCH2), 73.4 (C-4A), 73.1 (2 C, C-3B, C-5B), 72.6 (C-4C), 72.1 (PhCH2), 71.2 (C-2C), 70.4 (C-2B), 68.3 (C-6C), 67.9 (C-6A), 66.5 (2 C, C-6B, C-4B), 55.5 (OCH3), 21.0, 20.8, 20.7 (3 C, 3 COCH3).
ESI-MS: m/z = 1299.4 [M + Na]+.
Anal. Calcd for C73H80O20 (1276.52): C, 68.64; H, 6.31. Found: C, 68.45; H, 6.55.
4-Methoxyphenyl (3,4,6-Tri- O -benzyl-β- d -galactopyranosyl)-(1→6)-(β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (11)
A soln of 10 (2.5 g, 2 mmol) in 0.1 M NaOMe in MeOH (mL) was allowed to stir at r.t. for 4 h and was then neutralized with Amberlite-IR 120 (H+) resin. The mixture was filtered and then evaporated to dryness; this gave the crude product, which was passed through a short column of silica gel (toluene-EtOAc, 1:1); this gave pure 11.
Yield: 2.3 g (100%); R f = 0.3 (toluene-EtOAc, 1:2); white solid; mp 168-69 ˚C; [α]D ²5 +3.6 (c 1.5, CHCl3).
IR (KBr): 3449, 3020, 2926, 2364, 1505, 1216, 1064, 763, 669 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.37-7.17 (m, 30 H, Ar-H), 6.98 (d, J = 9.0 Hz, 2 H, Ar-H), 6.78 (d, J = 9.0 Hz, 2 H, Ar-H), 4.97 (d, J = 11.2 Hz, 1 H, PhCH 2), 4.92 (d, J = 11.0 Hz, 1 H PhCH 2), 4.85 (d, J = 4.86 Hz, 1 H, H-1A), 4.82-4.77 (m, 3 H, PhCH 2), 4.71-4.63 (m, 3 H, PhCH 2), 4.54 (d, J = 12.1 Hz, 1 H, PhCH 2), 4.53 (d, J = 11.7 Hz, 1 H, PhCH 2), 4.42 (d, J = 12.4 Hz, 1 H, PhCH 2), 4.41 (d, J = 6.3 Hz, 1 H, H-1B), 4.38 (d, J = 11.8 Hz, 1 H, PhCH 2), 4.07 (d, J = 7.7 Hz, 1 H, H-1C), 4.06-4.02 (m, 1 H, H-3A), 3.99-3.82 (m, 4 H, H-6abA, H-2C, H-6aB), 3.78-3.76 (m, 1 H, H-4B), 3.75 (s, 3 H, OCH 3), 3.68-3.66 (m, 2 H, H-2A, H-2B), 3.62-3.58 (m, 1 H, H-6bB), 3.56-3.49 (m, 3 H, H-4C, H-3B, H-6aC), 3.46-3.44 (m, 1 H, H-6bC), 3.41-3.32 (m, 4 H, H-3C, H-5C, H-4A, H-5A), 3.30-3.28 (m, 1 H, H-5B).
¹³C NMR (75 MHz, CDCl3): δ = 155.2-114.5 (Ar-C), 103.5 (C-1C), 102.8 (C-1A), 102.7 (C-1B), 83.0 (C-2A), 82.2 (C-5A), 81.7 (C-5C), 76.2 (C-3A), 75.5 (PhCH2), 75.0 (C-4C), 74.7 (PhCH2), 74.6 (PhCH2), 73.5 (2 C, C-4A, C-3C), 73.4 (2 C, 2PhCH2), 73.3 (C-5B), 73.1 (C-3B), 72.7 (PhCH2), 72.1 (C-2B), 71.2 (C-2C), 68.4 (C-6C), 68.3 (C-6B), 68.1 (C-4B), 67.8 (C-6A), 55.4 (OCH3).
ESI-MS: m/z = 1168.2 [M + NH4]+.
Anal. Calcd for C67H74O17 (1150.49): C, 69.90; H, 6.48. Found: C, 69.70; H, 6.72.
4-Methoxyphenyl (Methyl 5-Acetamido-4,7,8,9-tetra- O -acetyl-3,5-dideoxy-d-glycero-α- d -galacto-2-nonulopyranosylonate)-(2→3)-[(3,4,6-tri- O -benzyl-β- d -galactopyranosyl)-(1→6)]-(β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (12)
To a soln of 11 (1 g, 0.87 mmol) and thioglycoside donor 7 (0.9 g, 1.7 mmol) in anhyd MeCN-CH2Cl2 (5:1; 20 mL) was added 3 Å MS (2 g), and the mixture was allowed to stir at r.t. under argon for 30 min. The mixture was cooled to -30 ˚C and NIS (500 mg, 2.3 mmol) and TMSOTf (15 µL) were added. After the mixture had stirred at the same temperature for 20 h, it was filtered through a Celite bed and washed with CH2Cl2 (100 mL). The organic layer was washed with 5% Na2S2O3 (100 mL), sat. aq NaHCO3 (100 mL), and H2O (100 mL) in succession, dried (Na2SO4), and evaporated to dryness. The crude mass was purified by chromatography (silica gel, toluene-EtOAc, 1:2); this gave pure 12.
Yield: 650 mg (50%); R f = 0.2 (toluene-EtOAc, 1:3); white solid; mp 127-29 ˚C; [α]D ²5 +8.4 (c 1.5, CHCl3).
IR (KBr): 3020, 2925, 2855, 2364, 1742, 1506, 1370, 1217, 1062, 765, 669 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.43-7.22 (m, 30 H, Ar-H), 7.01 (d, J = 9.0 Hz, 2 H, Ar-H), 6.77 (d, J = 9.1 Hz, 2 H, Ar-H), 5.46-5.44 (m, 1 H, H-8D), 5.35-5.29 (m, 1 H, H-7D), 5.04 (d, J = 12.1 Hz, 1 H, PhCH 2), 4.98 (d, J = 12.5 Hz, 1 H, PhCH 2), 4.88 (d, J = 5.0 Hz, 1 H, H-4D), 4.85 (d, J = 8.6 Hz, 1 H, H-1A), 4.82 (d, J = 10.3 Hz, 1 H, PhCH 2), 4.79 (d, J = 10.6 Hz, 1 H, PhCH 2), 4.72-4.62 (m, 4 H, PhCH 2), 4.60 (d, J = 4.4 Hz, 1 H, H-1B), 4.54 (d, J = 11.4 Hz, 1 H, PhCH 2), 4.52 (d, J = 11.2 Hz, 1 H, PhCH 2), 4.49 (d, J = 11.8 Hz, 1 H, PhCH 2), 4.39 (d, J = 11.8 Hz., 1 H, PhCH 2), 4.28 (dd, J = 10.1, 3.9 Hz, 1 H, H-9aD), 4.18-3.97 (m, 7 H, H-1C, H-4B, H-9bD, H-5D, H-6D, H-3A, H-3B), 3.87-3.78 (m, 4 H, H-2C, H-2B, H-6abA), 3.75-3.69 (m, 3 H, H-2A, H-4C, H-6aB), 3.73 (s, 3 H, OCH 3), 3.66-3.64 (m, 1 H, H-6bB), 3.63 (s, 3 H, COOCH 3), 3.56-3.53 (m, 2 H, H-4A, H-6aC), 3.50-3.45 (m, 2 H, H-3C, H-6bC), 3.37-3.29 (m, 3 H, H-5A, H-5B, H-5C), 2.71 (dd, J = 12.3, 4.5 Hz, 1 H, H-3eD), 2.10-1.89 (5 s, 15 H, 5 COCH 3), 2.00-1.98 (m, 1 H, H-3aD).
¹³C NMR (75 MHz, CDCl3): δ = 170.8, 170.4, 170.3, 169.9 (2 C), 168.1 (5 COCH3, COOCH3), 155.0-114.4 (Ar-C), 103.4 (C-1C), 102.5 (C-1A), 102.3 (C-1B), 97.5 (C-2D), 82.9 (C-2A), 82.1 (C-5A), 81.6 (C-5C), 76.8 (C-3A), 76.4 (C-4B), 76.3 (PhCH2), 75.6 (C-3C), 75.1 (C-3B), 74.8 (PhCH2), 74.6 (PhCH2), 73.4 (PhCH2), 73.2 (C-4A), 73.1 (C-5B), 73.0 (PhCH2), 72.6 (2 C, PhCH2, C-6D), 71.2 (C-2B), 69.9 (C-2C), 68.7 (C-6C), 68.5 (C-8D), 68.3 (C-6B), 68.2 (C-4D), 67.5 (C-6A), 66.9 (2 C, C-7D, C-4C), 62.1 (C-9D), 55.5 (OCH3), 53.0 (COOCH3), 49.3 (C-5D), 37.7 (C-3D), 23.0 (NHCOOCH3), 21.1, 20.7, 20.6, 20.5 (4 COCH3).
ESI-MS: m/z = 1646.5 [M + Na]+.
Anal. Calcd for C87H101NO29 (1623.64): C, 64.31; H, 6.27; found: C, 64.12; H, 6.50.
4-Methoxyphenyl (4,6- O -Benzylidene-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (13)
A soln of 8 (3 g, 3.4 mmol) in 0.1 M NaOMe in MeOH (100 mL) was allowed to stir at r.t. for 2 h and then neutralized with Amberlite-IR 120 (H+) resin. The mixture was filtered and evaporated to dryness to give the crude product, which was passed through a short column of silica gel (hexane-EtOAc, 2:1); this gave pure 13.
Yield: 2.73 g (100%); R f = 0.3 (hexane-EtOAc, 1:1); yellow oil; [α]D ²5 -25.3 (c 1.5, CHCl3).
IR (neat): 3416, 2919, 2851, 2362, 1734, 1505, 1459, 1218, 1059, 766, 698 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.48-7.23 (m, 20 H, Ar-H), 7.02 (d, J = 9.0 Hz, 2 H, Ar-H), 6.82 (d, J = 9.0 Hz, 2 H, Ar-H), 5.46 (s, 1 H, PhCH), 5.10 (d, J = 11.0 Hz, 1 H, PhCH 2), 5.03 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.95 (d, J = 11.1 Hz, 1 H, PhCH 2), 4.88 (d, J = 7.3Hz, 1 H, H-1A), 4.83 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.71 (d, J = 12.1 Hz, 1 H, PhCH 2), 4.59 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.56 (d, J = 7.5 Hz, 1 H, H-1B), 4.11-4.01 (m, 4 H, H-3A, H-4B, H-6aA, H-6aB), 3.89-3.85 (m, 2 H, H-6bA, H-6bB), 3.78 (s, 3 H, OCH 3), 3.76-3.72 (m, 3 H, H-2A, H-5A, H-5B), 3.69-3.56 (m, 2 H, H-2B, H-4A), 3.48-3.39 (m, 1 H, H-3B).
¹³C NMR (75 MHz, CDCl3): δ = 155.3-114.5 (Ar-C), 103.4 (C-1B), 102.9 (C-1A), 101.2 (PhCH), 83.4 (C-2A), 81.8 (C-5A), 77.5 (C-3A), 75.5 (PhCH2), 75.2 (C-4B), 75.0 (PhCH2), 74.7 (C-2B), 73.3 (2 C, PhCH2, C-4A), 72.8 (C-3B), 72.0 (C-5B), 68.8 (C-6A), 68.2 (C-6B), 55.4 (OCH3).
ESI-MS: m/z = 829.3 [M + Na]+.
Anal. Calcd for C47H50O12 (806.33): C, 69.96; H, 6.25. Found: C, 69.75; H, 6.50.
4-Methoxyphenyl (2,3,4,6-Tetra- O -acetyl-β- d -galactopyranosyl)-(1→3)-(2- O -acetyl-4,6- O -benzylidene-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (14)
To a soln of 13 (2 g, 2.5 mmol) and thioglycoside donor 6 (1.1 g, 2.7 mmol) in CH2Cl2 (40 mL) was added 4 Å MS (5 g), and the mixture was allowed to stir at r.t. under argon for 30 min. The mixture was cooled to -50 ˚C and NIS (790 mg, 3.5 mmol) and TMSOTf (10 µL) were added. After the mixture had stirred at the same temperature for 30 min, it was filtered through a Celite bed and washed with CH2Cl2 (100 mL). The organic layer was washed with 5% Na2S2O3 (100 mL), sat. aq NaHCO3 (100 mL), and H2O (100 mL) in succession, dried (Na2SO4), and evaporated to dryness. The crude mass was acetylated with Ac2O (5 mL) and py (5 mL) at r.t. The acetylated crude mass was purified by chromatography (silica gel, hexane-EtOAc, 3:1); this gave pure 14.
Yield: 2.2 g (74%); R f = 0.4 (hexane-EtOAc, 1:1); white solid; mp 130-32 ˚C; [α]D ²5 -3.7 (c 1.5, CHCl3).
IR (KBr): 3465, 2871, 1751, 1507, 1370, 1226, 1061, 751, 699 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.50-7.15 (m, 20 H, Ar-H), 6.98 (d, J = 9.0 Hz, 2 H, Ar-H), 6.77 (d, J = 9.0 Hz, 2 H, Ar-H), 5.50 (s, 1 H, PhCH), 5.35-5.34 (m, 1 H, H-4C), 5.29-5.23 (m, 1 H, H-2B), 5.15 (dd, J = 10.4, 8.0 Hz, 1 H, H-2C), 5.06 (d, J = 11.1 Hz, 1 H, PhCH 2), 4.98 (d, J = 11.1 Hz, 1 H, PhCH 2), 4.93 (t, J = 5.3 Hz, 1 H, H-3C), 4.82 (d, J = 11.1 Hz, 1 H, PhCH 2), 4.80 (d, J = 7.5 Hz, 1 H, H-1A), 4.78-4.71 (2 d, J = 11.8 Hz, 2 H, PhCH 2), 4.62 (d, J = 7.9 Hz, 1 H, H-1B), 4.58 (d, J = 8.0 Hz, 1 H, H-1C), 4.51 (d, J = 11.9 Hz, 1 H, PhCH 2), 4.24-4.08 (m, 4 H, H-6abC, H-6aA, H-4B), 3.97-3.87 (m, 3 H, H-3A, H-6bA, H-5C), 3.82-3.72 (m, 3 H, H-6abB, H-5A), 3.75 (s, 3 H, OCH 3), 3.69-3.64 (m, 2 H, H-5B, H-2A), 3.60 (dd, J = 10.3, 3.5 Hz, 1 H, H-3B), 3.47-3.44 (m, 1 H, H-4A), 2.19, 2.06, 2.05, 2.04, 1.99 (5 s, 15 H, 5 COCH 3).
¹³C NMR (75 MHz, CDCl3): δ = 170.1, 170.0, 169.9, 168.9, 168.5 (5 COCH3), 155.3-114.5 (Ar-C), 102.7 (C-1A), 101.6 (C-1B), 100.9 (C-1C), 100.6 (PhCH), 82.9 (C-2A), 81.6 (C-5B), 77.3 (C-3A), 77.2 (C-3B), 75.7 (C-4B), 75.5 (PhCH2), 75.1 (C-4A), 74.9 (PhCH2), 73.6 (PhCH2), 70.9 (C-2B), 70.8 (C-3C), 70.7 (C-5C), 68.4 (2 C, C-2C, C-5A), 67.9 (C-6B), 66.8 (C-4C), 61.1 (2 C, C-6A, C-6C), 55.4 (OCH3), 21.0, 20.6 (2 C), 20.5 (2 C) (5 COCH3).
ESI-MS: m/z = 1201.3 [M + Na]+.
Anal. Calcd for C63H70O22 (1178.43): C, 64.17; H, 5.98. Found: C, 64.0; H, 6.20.
4-Methoxyphenyl (2,3,4,6-Tetra- O -acetyl-β- d -galactopyranosyl)-(1→3)-(2- O -acetyl-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (15)
HClO4˙SiO2 (500 mg) was added to a soln of 14 (2 g, 1.7 mmol) in MeCN-H2O (9:1; 50 mL), and the mixture was allowed to stir at r.t. for 30 min. It was then filtered through a Celite bed and evaporated to dryness. The crude product was purified through a short pad of silica gel (toluene-EtOAc, 1:1); this gave pure 15.
Yield: 1.7 g (92%); R f = 0.4 (toluene-EtOAc, 1:2); colorless oil; [α]D ²5 -12.3 (c 1.5, CHCl3).
IR (neat): 3482, 2920, 2361, 1749, 1506, 1370, 1225, 1062, 755 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.39-7.25 (m, 15 H, Ar-H), 6.98 (d, J = 9.0 Hz, 2 H, Ar-H), 6.78 (d, J = 9.0 Hz, 2 H, Ar-H), 5.35-5.34 (m, 1 H, H-4C), 5.19-5.12 (m, 2 H, H-2B, H-2C), 4.99-4.94 (m, 3 H, H-3C, 2 PhCH 2), 4.81 (d, J = 8.1 Hz, 1 H, H-1A), 4.78 (d, J = 10.6 Hz, 1 H, PhCH 2), 4.76 (d, J = 12.3 Hz, 1 H, PhCH 2), 4.73 (d, J = 12.0 Hz, 1 H, PhCH 2), 4.53 (d, J = 8.0 Hz, 1 H, H-1B), 4.49 (d, J = 11.2 Hz, 1 H, PhCH 2), 4.46 (d, J = 7.8 Hz, 1 H, H-1C), 4.19-4.05 (m, 2 H, H-6abC), 3.94-3.89 (m, 3 H, H-4B, H-5C, H-3A), 3.77 (s, 3 H, OCH 3), 3.75-3.68 (m, 2 H, H-6abA), 3.67-3.58 (m, 3 H, H-5B, H-6aB, H-2A), 3.55-3.44 (m, 3 H, H-3B, H-6bB, H-4A), 3.32-3.28 (m, 1 H, H-5A), 2.16, 2.06, 1.98 (3 s, 15 H, 5 COCH 3).
¹³C NMR (75 MHz, CDCl3): δ = 170.2, 170.0, 169.9, 169.0, 168.6 (5 COCH3), 155.3-114.5 (Ar-C), 102.8 (C-1A), 101.5 (C-1B), 100.3 (C-1C), 82.4 (C-2A), 81.3 (C-5B), 80.1 (C-3B), 76.6 (C-3A), 75.5 (PhCH2), 75.1 (C-4A), 74.9 (PhCH2), 74.6 (C-5A), 73.6 (PhCH2), 71.1 (C-2C), 70.9 (C-3C), 70.6 (C-4B), 68.7 (C-5C), 68.5 (C-2B), 67.9 (C-6A), 66.9 (C-4C), 61.6 (C-6B), 61.3 (C-6C), 55.5 (OCH3), 20.8 (2 C), 20.6, 20.5, 20.4 (5 COCH3).
ESI-MS: m/z = 1113.2 [M + Na]+.
Anal. Calcd for C56H66O22 (1090.40): C, 61.64; H, 6.10. Found: C, 61.46; H, 6.32.
4-Methoxyphenyl (Methyl 5-Acetamido-4,7,8,9-tetra- O -acetyl-3,5-dideoxy- d -glycero-α- d -galacto-2-nonulopyranosylonate)-(2→6)-[(2,3,4,6-tetra- O -acetyl-β- d -galactopyranosyl)-(1→3)]-(2- O -acetyl-β- d -galactopyranosyl)-(1→4)-2,3,6-tri- O -benzyl-β- d -glucopyranoside (16)
To a soln of 15 (1 g, 0.92 mmol) and thioglycoside donor 7 (960 mg, 1.8 mmol) in anhyd MeCN-CH2Cl2 (5:1; 15 mL) was added 3 Å MS (2 g), and the mixture was allowed to stir at r.t. under argon for 30 min. The mixture was cooled to -30 ˚C and NIS (525 mg, 2.3 mmol) and TMSOTf (10 µL) were added. After the mixture had stirred at the same temperature for 3 h, it was filtered through a Celite bed and washed with CH2Cl2 (100 mL). The organic layer was washed with 5% Na2S2O3 (100 mL), sat. aq NaHCO3 (100 mL), and H2O (100 mL) in succession, dried (Na2SO4), and evaporated to dryness. The crude mass was purified by chromatography (silica gel, toluene-EtOAc, 1:2); this gave pure 16.
Yield: 940 mg (67%); R f = 0.3 (toluene-EtOAc, 1:3); white solid; mp 142-44 ˚C; [α]D ²5 -11.4 (c 1.5, CHCl3).
IR (KBr): 3486, 2925, 1748, 1507, 1371, 1226, 1064, 741, 699 cm-¹.
¹H NMR (300 MHz, CDCl3): δ = 7.39-7.24 (m, 15 H, Ar-H), 7.00 (d, J = 9.0 Hz, 2 H, Ar-H), 6.78 (d, J = 9.1 Hz, 2 H, Ar-H), 5.39-5.32 (m, 3 H, H-7D, H-8D, H-4C), 5.26-5.15 (m, 3 H, H-2C, H-2B, H-6D), 5.02-4.93 (m, 3 H, H-3C, H-4D, PhCH 2), 4.86 (d, J = 7.7 Hz, 1 H, H-1A), 4.85 (d, J = 11.3 Hz, 1 H, PhCH 2), 4.77 (d, J = 11.1 Hz, 1 H, PhCH 2), 4.75 (d, J = 11.0 Hz, 1 H, PhCH 2), 4.69 (d, J = 8.2 Hz, 1 H, H-1B), 4.65 (d, J = 8.0 Hz, 1 H, H-5D), 4.57 (d, J = 8.0 Hz, 1 H, H-1C), 4.53 (d, J = 12.7 Hz, 1 H, PhCH 2), 4.35-4.25 (m, 1 H, H-6aC), 4.24-4.18 (m, 1 H, H-6aB), 4.13-4.04 (m, 4 H, H-5C, H-9aD, H-6bC, H-6bB), 3.95-3.90 (m, 3 H, H-4B, H-5A, H-9bD), 3.82-3.72 (m, 2 H, H-6abA), 3.76 (s, 6 H, OCH 3 and COOCH 3), 3.71-3.62 (m, 2 H, H-5B, H-2A), 3.58-3.51 (m, 2 H, H-3B, H-4A), 3.38 (t, J = 7.0 Hz, 1 H, H-3A), 2.55 (dd, J = 12.1, 4.4 Hz, 1 H, H-3eD), 2.16-1.88 (10 s, 30 H, 10 COCH 3), 1.99-1.89 (m, 1 H, H-3aD).
¹³C NMR (75 MHz, CDCl3): δ = 170.9, 170.7, 170.5, 170.3 (2 C), 170.2, 170.1, 170.0, 169.3, 168.9, 167.9 (9 COCH3, COOCH3, NHCOCH3), 155.3-114.5 (Ar-C), 102.6 (C-1A), 101.5 (C-1C), 100.0 (C-1B), 99.0 (C-2D), 82.4 (C-2A), 81.7 (C-5B), 79.5 (C-3B), 76.4 (C-5A), 74.9 (C-4A), 74.8 (2 C, 2 PhCH2), 73.7 (C-4B), 73.6 (PhCH2), 72.9 (C-5C), 72.3 (C-3A), 71.4 (C-2B), 71.3 (C-2C), 70.8 (2 C, C-3C, C-4D), 69.3 (C-4C), 69.1 (C-6D), 68.5 (C-9D), 67.6 (C-7D), 66.8 (C-8D), 62.4 (C-6C), 62.1 (C-6B), 60.9 (C-6A), 55.6 (OCH3), 52.9 (COOCH3), 49.4 (C-5D), 37.0 (C-3D), 22.7 (NHCOCH3), 21.1, 21.0, 20.9, 20.8, 20.7, 20.6 (2 C), 20.5, 20.3 (9 COCH3).
ESI-MS: m/z = 1581.1 [M + NH4]+.
Anal. Calcd for C76H93NO34 (1563.56): C, 58.34; H, 5.99. Found: C, 58.13; H, 6.25.
4-Methoxyphenyl (Sodium 5-Acetamido-3,5-dideoxy- d -glycero-α- d -galacto-2-nonulopyranosylonate)-(2→3)-[(β- d -galactopyranosyl)-(1→6)]-(β- d -galactopyranosyl)-(1→4)-β- d -gluco-pyranoside (1)
To a soln of the tetrasaccharide derivative 12 (500 mg, 0.33 mmol) in MeOH (20 mL) was added 20% Pd(OH)2/C (400 mg), and the mixture was allowed to stir at r.t. for 24 h under a positive pressure of H2. The mixture was filtered through a Celite bed and concentrated under reduced pressure. The crude mass was dissolved in 0.1 M NaOMe in MeOH (30 mL), and the mixture was allowed to stir at r.t. for 12 h; then a few drops of distilled H2O was added, and the mixture was allowed to stir for 6 h. The mixture was neutralized with Dowex 50W X8 (H+) resin, filtered, and evaporated to dryness and again passed through a short pad of Dowex 50W X8 (Na+) resin. The crude product was purified by being passed through a column of Sephadex-LH-20 (MeOH-H2O, 4:1); this gave tetrasaccharide 1 as its sodium salt.
Yield: 215 mg (70%); R f = 0.2 (MeCN-MeOH-H2O, 4:1:0.5); white powder; [α]D ²5 -9.3 (c 1.1, H2O).
IR (KBr): 3443, 3021, 1637, 1216, 767, 669 cm-¹.
¹H NMR (300 MHz, D2O): δ = 7.01 (d, J = 9.0 Hz, 2 H, Ar-H), 6.80 (d, J = 9.0 Hz, 2 H, Ar-H), 4.79 (d, J = 7.3 Hz, 1 H, H-1A), 4.42 (d, J = 7.9 Hz, 1 H, H-1B), 4.28 (d, J = 7.0 Hz, 1 H, H-1C), 4.06-3.96 (m, 2 H, H-8D, H-7D), 3.92-3.75 (m, 9 H, H-4D, H-9aD, H-6D, H-5D, H-3A, H-6abB, H-6abA), 3.72-3.65 (m, 3 H, H-4B, H-6abC), 3.71 (s, 3 H, OCH 3), 3.65-3.55 (m, 5 H, H-2B, H-9bD, H-3B, H-3C, H-4C), 3.52-3.43 (m, 6 H, H-2A, H-2C, H-5B, H-5A, H-5C, H-4A), 2.74 (dd, J = 12.1, 3.7 Hz, 1 H, H-3eD), 1.97 (s, 3 H, NHCOCH 3), 1.87 (t, J = 11.8 Hz, 1 H, H-3aD).
¹³C NMR (75 MHz, D2O): δ = 174.0 (COONa), 155.6-114.5 (Ar-C), 104.3 (C-2D), 104.2 (2 C, C-1C, C-1B), 101.9 (C-1A), 81.2 (C-5A), 76.5 (C-7D), 75.5 (2 C, C-2A, C-2C), 75.2 (C-4A), 74.3 (2 C, C-4C, C-5B), 73.6 (C-5C), 73.4 (C-4D), 71.6 (2 C, C-3A, C-3C), 69.5 (C-8D), 69.3 (C-6D), 69.0 (C-2B), 68.8 (C-6A), 68.4 (C-3B), 67.7 (C-4B), 63.7 (C-9D), 61.5 (C-6B), 61.0 (C-6C), 55.1 (OCH3), 52.7 (C-5D), 39.9 (C-3D), 22.6 (NHCOCH3).
ESI-MS: m/z = 924.1 [M + 1]+.
Anal. Calcd for C36H54NNaO25 (923.28): C, 46.81; H, 5.89. Found: C, 46.60; H, 6.15.
4-Methoxyphenyl (Sodium 5-acetamido-3,5-dideoxy- d -glycero-α-d-galacto-2-nonulopyranosylonate)-(2→6)-[(β- d -galactopyranosyl)-(1→3)]-(β- d -galactopyranosyl)-(1→4)-β- d -glucopyranoside (2)
To a soln of the tetrasaccharide derivative 16 (600 mg, 0.38 mmol) in MeOH (20 mL) was added 20% Pd(OH)2/C (400 mg), and the mixture was allowed to stir at r.t. for 24 h under a positive pressure of H2. The mixture was filtered through a Celite bed and concentrated under reduced pressure. The crude mass was dissolved in 0.1 M NaOMe in MeOH (30 mL), and the mixture was allowed to stir at r.t. for 12 h; then a few drops of distilled H2O was added, and the mixture was allowed to stir for 6 h. The mixture was neutralized with Dowex 50W X8 (H+) resin, filtered, and evaporated to dryness, before it was again passed through a short pad of Dowex 50W X8 (Na+) resin. The crude product was purified by being passed through a column of Sephadex-LH-20 (MeOH-H2O, 4:1); this gave tetrasaccharide 2 as its sodium salt.
Yield: 250 mg (72%); R f = 0.3 (MeCN-MeOH-H2O, 4:1:0.5); white powder; [α]D ²5 -8.7 (c 1.1, H2O).
IR (KBr): 3021, 2926, 2401, 1216, 767, 670 cm-¹.
¹H NMR (300 MHz, D2O): δ = 7.01 (d, J = 8.9 Hz, 2 H, Ar-H), 6.80 (d, J = 8.9 Hz, 2 H, Ar-H), 4.79 (d, J = 7.3 Hz, 1 H, H-1A), 4.47 (d, J = 7.3 Hz, 1 H, H-1B), 4.41 (d, J = 7.5 Hz, 1 H, H-1C), 4.14-4.05 (m, 3 H, H-8D, H-7D, H-9aD), 3.91-3.76 (m, 7 H, H-4D, H-5D, H-4B, H-6D, H-6abA, H-9bD), 3.75-3.67 (m, 3 H, H-2C, H-6abC), 3.71 (s, 3 H, OCH 3), 3.64-3.57 (m, 6 H, H-3A, H-2B, H-5B, H-3C, H-6abB), 3.55-3.44 (m, 6 H, H-2A, H-4A, H-5A, H-3B, H-4C, H-5C), 2.73 (dd, J = 12.3, 4.2 Hz, 1 H, H-3eD), 1.96 (s, 3 H, NHCOCH 3), 1.75 (t, J = 11.9 Hz, 1 H, H-3aD).
¹³C NMR (75 MHz, D2O): δ = 174.4 (COONa), 173.9 (NHCOCH3), 155.6-114.5 (Ar-C), 105.3 (C-1B), 103.7 (C-1C), 101.9 (C-1A), 99.5 (C-2D), 83.4 (C-2C), 80.5 (C-5B), 75.7 (C-2B), 75.2 (2 C, C-3A, C-3C), 74.1 (C-4A), 73.7 (C-5A), 73.5 (2 C, C-3B, C-4C), 71.9 (2 C, C-4D, C-6D), 70.4 (C-4B), 69.3 (C-8D), 69.2 (C-7D), 68.8 (C-5C), 68.3 (C-2A), 63.6 (C-9D), 63.1 (C-6B), 61.5 (C-6C), 60.9 (C-6A), 55.1 (OCH3), 52.6 (C-5D), 40.8 (C-3D), 21.9 (NHCOCH3).
ESI-MS: m/z = 924.2 [M + 1]+.
Anal. Calcd for C36H54NNaO25 (923.28): C, 46.81; H, 5.89. Found: C, 46.58; H, 6.18.
Acknowledgment
Instrumentation facilities from SAIF, CDRI, Lucknow is gratefully acknowledged. P.K.M. thanks CSIR, New Delhi for providing a Senior Research fellowship. A.K.M. thanks the Department of Science and Technology (DST), New Delhi for providing a Ramanna Fellowship (SR/S1/RFPC-06/2006).
- 1a
Newburg DS.Neubaur SH. Handbook of Milk Composition Academic Press; San Diego: 1995. p.273-349 - 1b
Stahl B.Thurl S.Zeng J.Karas M.Hillenkamp F.Steup M.Sawatzki G. Anal. Biochem. 1994, 223: 218 - 2a
Holmgren J.Svennerholm AM.Lindblad M. Infect. Immun. 1983, 39: 147 - 2b
Chaturvedi P.Warren CD.Altaye M.Morrow AL.Ruiz-Palacios G.Pickering LK.Newburg DS. Glycobiology 2001, 11: 365 - 2c
Gothefors L.Olling S.Winberg J. Acta Pediatr. Scand. 1975, 64: 807 - 2d
Andersson B.Porras O.Hanson LA.Lagergard T.Svanborg-Eden C. J. Infect. Dis. 1986, 153: 232 - 2e
Coppa GV.Gabrielli O.Pierani P.Catassi C.Carlucci A.Giorgi P. Pediatrics 1993, 91: 637 - 2f
Crane JK.Azar SS.Stam A.Newburg DS. J. Nutr. 1994, 124: 2358 - 2g
Gyorgy P.Jeanloz RW.von Nicolai H.Zilliken F. Eur. J. Biochem. 1974, 43: 29 - 2h
Ofek I.Beachey EH. Adv. Intern. Med. 1980, 25: 503 - 2i
Laegreid A.Otnaess ABK.Fuglesang J. Pediatr. Res. 1986, 20: 416 - 2j
Zopf D.Roth S. Lancet 1996, 347: 1017 - 2k
Cravioto A.Tello A.Villafan H.Ruiz J.Del Vedovo S.Neeser J.-R. J. Infect. Dis. 1991, 163: 1247 - 2l
Newburg DS.Pickering LK.McCluer RH.Cleary TC. J. Infect. Dis. 1990, 162: 1075 - 3
Coppa GV.Gabrielli O.Giorgi P.Catassi C.Montanari MP.Varaldo PE.Nichols BL. Lancet 1990, 335: 569 - 4a
Feizi T. Nature 1985, 314: 53 - 4b
Wieruszeski JM.Chekkor A.Bouquelet S.Montreuil J.Strecker G.Peter-Katalinic J.Egge H. Carbohydr. Res. 1985, 137: 127 - 4c
Strecker G.Fievre S.Wieruszeski JM.Michalski JC.Montreuil J. Carbohydr. Res. 1992, 226: 1 - 4d
Dua VK.Goso K.Dube VE.Bush CA. J. Chromatogr. 1985, 328: 259 - 4e
Yamashita K.Mizuochi T.Kobata A. Methods Enzymol. 1982, 83: 105 - 5a
Gopal PK.Gill HS. Br. J. Nutr., Suppl. 1 2000, 84: S69 - 5b
Sharon N.Ofek I. Glycoconj. J. 2000, 17: 659 - 5c
Boedeker EC. Gastroenterology 1982, 83: 489 - 6a
Urashima T.Saito T.Nakamura T.Messer M. Glycoconj. J. 2001, 18: 357 - 6b
Messer M.Urashima T. Trends Glycosci. Glycotechnol. 2002, 14: 153 - 6c
Guerardel Y.Morelle W.Plancke Y.Lemoine J.Strecker G. Carbohydr. Res. 1999, 320: 230 - 6d
Saksena R.Deepak D.Khare A.Sahai R.Tripathi LM.Srivastava VML. Biochem. Biophys. Acta 1999, 1428: 433 - 6e
Chaturvedi P.Sharma CB. Biochim. Biophys. Acta 1988, 967: 115 - 6f
Urashima T.Bubb WA.Messer M.Tsuji Y.Taneda Y. Carbohydr. Res. 1994, 262: 173 - 7
Nakamura T.Urashima T. Trends Glycosci. Glycotechnol. 2004, 16: 135 - 8
Meijer A.Ellervik U. J. Org. Chem. 2004, 69: 6249 - 9
Yashunsky DU.Higson AP.Ross AJ.Nikolaev AV. Carbohydr. Res. 2001, 336: 243 - 10
Berces A.Whitfield DM.Nukada T.Santos IZ.Obuchowska A.Krepinsky JJ. Can. J. Chem. 2004, 82: 1157 - 11
Fried J.Walz DE. J. Am. Chem. Soc. 1949, 71: 140 - 12
Hasegawa A.Ohki H.Nagahama T.Ishida H.Kiso M. Carbohydr. Res. 1991, 212: 277 - 13a
Veeneman GH.van Leeuwen SH.van Boom JH. Tetrahedron Lett. 1990, 31: 1331 - 13b
Konradsson P.Udodong UE.Fraser-Reid B. Tetrahedron Lett. 1990, 31: 4313 - 14
Agnihotri G.Misra AK. Tetrahedron Lett. 2006, 47: 3653 - 15
Schmidt RR.Jung K.-H. Preparative Carbohydrate ChemistryHanessian S. Marcel Dekker; New York: 1997. p.283-312 - 16a
Hasegawa A.Kiso M. In Carbohydrates - Synthetic Methods and Applications in Medicinal ChemistryOgura H.Hasegawa A.Suami T. Wiley; New York: 1992. p.243-266 - 16b
Hasegawa A.Kiso M. In Preparative Carbohydrate ChemistryHanessian S. Marcel Dekker; New York: 1997. p.357-379 - 16c
Boons G.-J.Demchenko AV. Chem. Rev. 2000, 100: 4539 - 16d
Kanie O.Kiso M.Hasegawa A. J. Carbohydr. Chem. 1988, 7: 501 - 16e
Paulsen H.Tietz H. Angew. Chem., Int. Ed. Engl. 1982, 21: 927 - 16f
Hasegawa A.Nagahama T.Ohki T.Hotta K.Ishida H.Kiso M. J. Carbohydr. Chem. 1991, 10: 493 - 16g
Kiso M.Ando K.Inagaki H.Ishida H.Hasegawa A. Carbohydr. Res. 1995, 272: 159 - 16h
Castro-Palomino JC.Ritter G.Fortunato SR.Reinhardt S.Old LJ.Schmidt RR. Angew. Chem., Int. Ed. Engl. 1997, 36: 1998 - 16i
Iida M.Endo A.Fujita S.Numata M.Sugimoto M.Nunomura S.Ogawa T. J. Carbohydr. Chem. 1998, 17: 647 - 17
Pearlman WM. Tetrahedron Lett. 1967, 8: 1663
References
- 1a
Newburg DS.Neubaur SH. Handbook of Milk Composition Academic Press; San Diego: 1995. p.273-349 - 1b
Stahl B.Thurl S.Zeng J.Karas M.Hillenkamp F.Steup M.Sawatzki G. Anal. Biochem. 1994, 223: 218 - 2a
Holmgren J.Svennerholm AM.Lindblad M. Infect. Immun. 1983, 39: 147 - 2b
Chaturvedi P.Warren CD.Altaye M.Morrow AL.Ruiz-Palacios G.Pickering LK.Newburg DS. Glycobiology 2001, 11: 365 - 2c
Gothefors L.Olling S.Winberg J. Acta Pediatr. Scand. 1975, 64: 807 - 2d
Andersson B.Porras O.Hanson LA.Lagergard T.Svanborg-Eden C. J. Infect. Dis. 1986, 153: 232 - 2e
Coppa GV.Gabrielli O.Pierani P.Catassi C.Carlucci A.Giorgi P. Pediatrics 1993, 91: 637 - 2f
Crane JK.Azar SS.Stam A.Newburg DS. J. Nutr. 1994, 124: 2358 - 2g
Gyorgy P.Jeanloz RW.von Nicolai H.Zilliken F. Eur. J. Biochem. 1974, 43: 29 - 2h
Ofek I.Beachey EH. Adv. Intern. Med. 1980, 25: 503 - 2i
Laegreid A.Otnaess ABK.Fuglesang J. Pediatr. Res. 1986, 20: 416 - 2j
Zopf D.Roth S. Lancet 1996, 347: 1017 - 2k
Cravioto A.Tello A.Villafan H.Ruiz J.Del Vedovo S.Neeser J.-R. J. Infect. Dis. 1991, 163: 1247 - 2l
Newburg DS.Pickering LK.McCluer RH.Cleary TC. J. Infect. Dis. 1990, 162: 1075 - 3
Coppa GV.Gabrielli O.Giorgi P.Catassi C.Montanari MP.Varaldo PE.Nichols BL. Lancet 1990, 335: 569 - 4a
Feizi T. Nature 1985, 314: 53 - 4b
Wieruszeski JM.Chekkor A.Bouquelet S.Montreuil J.Strecker G.Peter-Katalinic J.Egge H. Carbohydr. Res. 1985, 137: 127 - 4c
Strecker G.Fievre S.Wieruszeski JM.Michalski JC.Montreuil J. Carbohydr. Res. 1992, 226: 1 - 4d
Dua VK.Goso K.Dube VE.Bush CA. J. Chromatogr. 1985, 328: 259 - 4e
Yamashita K.Mizuochi T.Kobata A. Methods Enzymol. 1982, 83: 105 - 5a
Gopal PK.Gill HS. Br. J. Nutr., Suppl. 1 2000, 84: S69 - 5b
Sharon N.Ofek I. Glycoconj. J. 2000, 17: 659 - 5c
Boedeker EC. Gastroenterology 1982, 83: 489 - 6a
Urashima T.Saito T.Nakamura T.Messer M. Glycoconj. J. 2001, 18: 357 - 6b
Messer M.Urashima T. Trends Glycosci. Glycotechnol. 2002, 14: 153 - 6c
Guerardel Y.Morelle W.Plancke Y.Lemoine J.Strecker G. Carbohydr. Res. 1999, 320: 230 - 6d
Saksena R.Deepak D.Khare A.Sahai R.Tripathi LM.Srivastava VML. Biochem. Biophys. Acta 1999, 1428: 433 - 6e
Chaturvedi P.Sharma CB. Biochim. Biophys. Acta 1988, 967: 115 - 6f
Urashima T.Bubb WA.Messer M.Tsuji Y.Taneda Y. Carbohydr. Res. 1994, 262: 173 - 7
Nakamura T.Urashima T. Trends Glycosci. Glycotechnol. 2004, 16: 135 - 8
Meijer A.Ellervik U. J. Org. Chem. 2004, 69: 6249 - 9
Yashunsky DU.Higson AP.Ross AJ.Nikolaev AV. Carbohydr. Res. 2001, 336: 243 - 10
Berces A.Whitfield DM.Nukada T.Santos IZ.Obuchowska A.Krepinsky JJ. Can. J. Chem. 2004, 82: 1157 - 11
Fried J.Walz DE. J. Am. Chem. Soc. 1949, 71: 140 - 12
Hasegawa A.Ohki H.Nagahama T.Ishida H.Kiso M. Carbohydr. Res. 1991, 212: 277 - 13a
Veeneman GH.van Leeuwen SH.van Boom JH. Tetrahedron Lett. 1990, 31: 1331 - 13b
Konradsson P.Udodong UE.Fraser-Reid B. Tetrahedron Lett. 1990, 31: 4313 - 14
Agnihotri G.Misra AK. Tetrahedron Lett. 2006, 47: 3653 - 15
Schmidt RR.Jung K.-H. Preparative Carbohydrate ChemistryHanessian S. Marcel Dekker; New York: 1997. p.283-312 - 16a
Hasegawa A.Kiso M. In Carbohydrates - Synthetic Methods and Applications in Medicinal ChemistryOgura H.Hasegawa A.Suami T. Wiley; New York: 1992. p.243-266 - 16b
Hasegawa A.Kiso M. In Preparative Carbohydrate ChemistryHanessian S. Marcel Dekker; New York: 1997. p.357-379 - 16c
Boons G.-J.Demchenko AV. Chem. Rev. 2000, 100: 4539 - 16d
Kanie O.Kiso M.Hasegawa A. J. Carbohydr. Chem. 1988, 7: 501 - 16e
Paulsen H.Tietz H. Angew. Chem., Int. Ed. Engl. 1982, 21: 927 - 16f
Hasegawa A.Nagahama T.Ohki T.Hotta K.Ishida H.Kiso M. J. Carbohydr. Chem. 1991, 10: 493 - 16g
Kiso M.Ando K.Inagaki H.Ishida H.Hasegawa A. Carbohydr. Res. 1995, 272: 159 - 16h
Castro-Palomino JC.Ritter G.Fortunato SR.Reinhardt S.Old LJ.Schmidt RR. Angew. Chem., Int. Ed. Engl. 1997, 36: 1998 - 16i
Iida M.Endo A.Fujita S.Numata M.Sugimoto M.Nunomura S.Ogawa T. J. Carbohydr. Chem. 1998, 17: 647 - 17
Pearlman WM. Tetrahedron Lett. 1967, 8: 1663
References

Figure 1 Structures of two synthesized sialylated tetrasaccharides as their 4-methoxyphenyl glycosides found in goat milk

Scheme 1 Reagents and conditions: (a) NIS, TMSOTf, 4 Å MS, CH2Cl2, -30 ˚C, 45 min, 92%; (b) HClO4˙SiO2, MeCN-H2O (9:1), r.t., 30 min, 95%; (c) 5, TMSOTf, 4 Å MS, CH2Cl2, -40 ˚C, 1 h, 82%; (d) 0.1 M NaOMe, MeOH, r.t., 4 h, 100%; (e) 7, NIS, TfOH, 3 Å MS, MeCN-CH2Cl2 (5:1), -30 ˚C, 20 h, 50%; (f) 1. H2, 20% Pd(OH)2/C, MeOH, r.t., 24 h; 2. 0.1 M NaOMe, MeOH, r.t., 12 h, then H2O (5 drops), r.t., 6 h, 70%.

Scheme 2 Reagents and conditions: (a) 0.1 M NaOMe, MeOH, r.t., 2 h, 100%; (b) 1. 6, NIS, TMSOTf, CH2Cl2, 4 Å MS, -50 ˚C, 45 min; 2. Ac2O, py, r.t., 2 h, 74% (2 steps); (c) HClO4˙SiO2, MeCN-H2O (9:1), r.t., 30 min, 92%; (d) 7, NIS, TfOH, 3 Å MS, MeCN-CH2Cl2 (5:1), -30 ˚C, 20 h, 67%; (e) 1. H2, 20% Pd(OH)2/C, MeOH, r.t., 24 h; 2. 0.1 M NaOMe, MeOH, r.t., 12 h, then H2O (5 drops), r.t., 6 h, 72%.

Figure 2 Suitably protected monosaccharide intermediates used for the preparation of compounds 1 and 2